GLOBAL STEM CELL MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

GLOBAL STEM CELL MARKET 2021-2028

Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Geography | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The detailed analysis of the global stem cell market shows that, in terms of revenue, the market is predicted to grow at a CAGR of 7.54% during the assessed years 2021-2028. In 2020, the market acquired revenue worth $9382 million, and is anticipated to garner $16782.2 million by 2028. 


Report scope can be customized per your requirements. Request For Customization

Stem cells have tremendous potential for cutaneous tissue regeneration, and promoting wound repair in a paracrine manner. The occurrences of chronic conditions are surging worldwide, owing to the rapidly aging population and greater longevity of people with chronic diseases. This has laid tremendous pressure on the healthcare system globally, thereby promoting the stem cell market's growth.

The stem cell market is not well-established in several therapeutic areas. However, it holds immense potential in diagnosis and therapeutic fields, with stem cell banking gaining importance with supportive government initiatives. Additionally, the number of stem cell banks has significantly grown in emerging economies, further aiding the growth of stem cell therapies.

The study aims to get an overview of the stem cell market in terms of various factors. Within this report, the key insight and the market summary regarding the stem cell market have been discussed. Further, industry components; legal, policy, & regulatory framework; the impact of COVID-19 on the market; key impact analysis; market attractiveness index; and vendor scorecard have been studied in depth.

Furthermore, the growing awareness about umbilical cord stem cells, a surge in stem cell research and development, and rising demand for regenerative medicine are key factors driving the stem cell market's progress. However, the ethical concerns associated with stem cells, the elevated cost of stem cell procedures, and stringent regulation relating to stem cell therapy, are restraints obstructing the studied market's development.

Nevertheless, opportunities such as technological advancement, along with the risk of adverse immune reactions and complications, can be leveraged by the stem cell market to reach its anticipated growth.



Geographies covered in the global stem cell market are:

•           North America: United States and Canada

•           Europe: United Kingdom, Germany, France, Italy, Spain, Russia, and Rest of Europe

•          Asia-Pacific: China, Japan, South Korea, India, ASEAN countries, New Zealand & Australia, and Rest of Asia-Pacific

•           Latin America: Mexico, Brazil, and Rest of Latin America

•          Middle East and Africa: Israel, Turkey, United Arab Emirates, South Africa, Saudi Arabia, and Rest of Middle East & Africa

The segmentation analysis of the stem cell market, in this report, includes:

•           Market by Therapeutic Application:

           o          Neurological Disorders

           o          Oncology Disorders

           o          Diabetes

           o          Injuries and Wounds

           o          Orthopedic Treatments

           o          Cardiovascular Disorders

           o          Other Therapeutic Applications

•           Market by Technology:

           o          Cryopreservation

           o          Acquisition

                     •           Stem Cell Apheresis

                     •           Stem Cell Bone Marrow Market

                     •           Stem Cell Umbilical Cord

           o          Expansion and Sub-Culture

           o          Production

                     •           Stem Cell Culture

                     •           Therapeutic Cloning

                     •           IVF

•           Market by Treatment Type:

           o          Allogeneic Stem Cell Therapy

           o          Autologic Stem Cell Therapy

           o          Syngeneic Stem Cell Therapy

•           Market by Product:

           o          Adult Stem Cell

                     •           Hematopoietic Stem Cell

                     •           Neural Stem Cell

                     •           Umbilical Cord Stem Cell

                     •           Mesenchymal Stem Cell

                     •           Dental Stem Cell

           o          Human Embryonic Stem Cell

           o          Pluripotent

           o          Mouse/Rat Neural

•           Market by Application:

           o          Regenerative Medicine

           o          Drug Discovery and Development

The key players engaged in the stem cell market are International Stem Cell Corp, GE Healthcare, Thermo Fisher Scientific Inc, Merck KGAA (Sigma Aldrich), Qiagen NV, Pluristem Therapeutics Inc, StemCell Technologies, Smith & Nephew Plc, AllCells LLC, Stryker Corporation, Takara Holdings, Corning Inc, Cytori Therapeutics, Becton Dickinson and Company (BD), and Miltenyi Biotec.      

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.  GLOBAL STEM CELL MARKET - SUMMARY

2.  INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON STEM CELL MARKET

2.3. KEY IMPACT ANALYSIS

2.4. INDUSTRY COMPONENTS

2.5. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY INSIGHTS

2.9. MARKET DRIVERS

2.9.1.   GROWING AWARENESS ABOUT UMBILICAL CORD STEM CELLS

2.9.2.   SURGE IN STEM CELL RESEARCH AND DEVELOPMENT

2.9.3.   RISING DEMAND FOR REGENERATIVE MEDICINE

2.10.  MARKET RESTRAINTS

2.10.1.   ETHICAL CONCERNS ASSOCIATED WITH STEM CELLS

2.10.2.   HIGH COST OF STEM CELL PROCEDURES

2.10.3.    STRINGENT REGULATIONS IN TERMS OF STEM CELL THERAPY

2.11.  MARKET OPPORTUNITIES

2.11.1.    ADVANCEMENT IN TECHNOLOGY

2.11.2.   RISK OF ADVERSE IMMUNE REACTIONS AND COMPLICATIONS

3.    GLOBAL STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. NEUROLOGICAL DISORDERS

3.2. ONCOLOGY DISORDERS

3.3. DIABETES

3.4. INJURIES AND WOUNDS

3.5. ORTHOPEDIC TREATMENTS

3.6. CARDIOVASCULAR DISORDERS

3.7. OTHER THERAPEUTIC APPLICATIONS

4.    GLOBAL STEM CELL MARKET OUTLOOK - BY TECHNOLOGY

4.1. CRYOPRESERVATION

4.2. ACQUISITION

4.2.1.   STEM CELL APHERESIS

4.2.2.   STEM CELL BONE MARROW MARKET

4.2.3.   STEM CELL UMBILICAL CORD

4.3. EXPANSION AND SUB-CULTURE

4.4. PRODUCTION

4.4.1.   STEM CELL CULTURE

4.4.2.   THERAPEUTIC CLONING

4.4.3.   IVF

5.    GLOBAL STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE

5.1. ALLOGENEIC STEM CELL THERAPY

5.2. AUTOLOGIC STEM CELL THERAPY

5.3. SYNGENEIC STEM CELL THERAPY

6.    GLOBAL STEM CELL MARKET OUTLOOK - BY PRODUCT

6.1. ADULT STEM CELL

6.1.1.   HEMATOPOIETIC STEM CELL

6.1.2.   NEURAL STEM CELL

6.1.3.   UMBILICAL CORD STEM CELL

6.1.4.   MESENCHYMAL STEM CELL

6.1.5.   DENTAL STEM CELL

6.2. HUMAN EMBRYONIC STEM CELL

6.3. PLURIPOTENT

6.4. MOUSE/RAT NEURAL

7.    GLOBAL STEM CELL MARKET OUTLOOK - BY APPLICATION

7.1. REGENERATIVE MEDICINE

7.2. DRUG DISCOVERY AND DEVELOPMENT

8.    GLOBAL STEM CELL MARKET - REGIONAL OUTLOOK

8.1. NORTH AMERICA

8.1.1.   MARKET BY THERAPEUTIC APPLICATION

8.1.2.   MARKET BY TECHNOLOGY

8.1.2.1.    MARKET BY ACQUISITION

8.1.2.2.    MARKET BY PRODUCTION

8.1.3.   MARKET BY TREATMENT TYPE

8.1.4.   MARKET BY PRODUCT

8.1.4.1.    ADULT STEM CELL MARKET BY TYPE

8.1.5.   MARKET BY APPLICATION

8.1.6.   COUNTRY ANALYSIS

8.1.6.1.    UNITED STATES

8.1.6.2.    CANADA

8.2. EUROPE

8.2.1.   MARKET BY THERAPEUTIC APPLICATION

8.2.2.   MARKET BY TECHNOLOGY

8.2.2.1.    MARKET BY ACQUISITION

8.2.2.2.    MARKET BY PRODUCTION

8.2.3.   MARKET BY TREATMENT TYPE

8.2.4.   MARKET BY PRODUCT

8.2.4.1.    ADULT STEM CELL MARKET BY TYPE

8.2.5.   MARKET BY APPLICATION

8.2.6.   COUNTRY ANALYSIS

8.2.6.1.    GERMANY

8.2.6.2.    FRANCE

8.2.6.3.    UNITED KINGDOM

8.2.6.4.    ITALY

8.2.6.5.    RUSSIA

8.2.6.6.    SPAIN

8.2.6.7.    REST OF EUROPE

8.3. ASIA-PACIFIC

8.3.1.   MARKET BY THERAPEUTIC APPLICATION

8.3.2.   MARKET BY TECHNOLOGY

8.3.2.1.    MARKET BY ACQUISITION

8.3.2.2.    MARKET BY PRODUCTION

8.3.3.   MARKET BY TREATMENT TYPE

8.3.4.   MARKET BY PRODUCT

8.3.4.1.    ADULT STEM CELL MARKET BY TYPE

8.3.5.   MARKET BY APPLICATION

8.3.6.   COUNTRY ANALYSIS

8.3.6.1.    CHINA

8.3.6.2.    JAPAN

8.3.6.3.    INDIA

8.3.6.4.    AUSTRALIA & NEW ZEALAND

8.3.6.5.    SOUTH KOREA

8.3.6.6.    ASEAN COUNTRIES

8.3.6.7.    REST OF ASIA-PACIFIC

8.4. LATIN AMERICA

8.4.1.   MARKET BY THERAPEUTIC APPLICATION

8.4.2.   MARKET BY TECHNOLOGY

8.4.2.1.    MARKET BY ACQUISITION

8.4.2.2.    MARKET BY PRODUCTION

8.4.3.   MARKET BY TREATMENT TYPE

8.4.4.   MARKET BY PRODUCT

8.4.4.1.    ADULT STEM CELL MARKET BY TYPE

8.4.5.   MARKET BY APPLICATION

8.4.6.   COUNTRY ANALYSIS

8.4.6.1.    MEXICO

8.4.6.2.    BRAZIL

8.4.6.3.    REST OF LATIN AMERICA

8.5. MIDDLE EAST AND AFRICA

8.5.1.   MARKET BY THERAPEUTIC APPLICATION

8.5.2.   MARKET BY TECHNOLOGY

8.5.2.1.    MARKET BY ACQUISITION

8.5.2.2.    MARKET BY PRODUCTION

8.5.3.   MARKET BY TREATMENT TYPE

8.5.4.   MARKET BY PRODUCT

8.5.4.1.    ADULT STEM CELL MARKET BY TYPE

8.5.5.   MARKET BY APPLICATION

8.5.6.   COUNTRY ANALYSIS

8.5.6.1.  ISRAEL

8.5.6.2   SAUDI ARABIA

8.5.6.3.    UNITED ARAB EMIRATES

8.5.6.4.    TURKEY

8.5.6.5.    SOUTH AFRICA

8.5.6.6.    REST OF MIDDLE EAST & AFRICA

9.    COMPANY PROFILES

9.1. CORNING INC

9.2. STEMCELL TECHNOLOGIES

9.3. STRYKER CORPORATION

9.4. BECTON DICKINSON AND COMPANY (BD)

9.5. CYTORI THERAPEUTICS

9.6. QIAGEN NV

9.7. GE HEALTHCARE

9.8. TAKARA HOLDINGS

9.9. SMITH & NEPHEW PLC

9.10. INTERNATIONAL STEM CELL CORP

9.11. MILTENYI BIOTEC

9.12. MERCK KGAA (SIGMA ALDRICH)

9.13. THERMOFISHER SCIENTIFIC INC

9.14.  ALLCELLS LLC

9.15. PLURISTEM THERAPEUTICS INC

10. RESEARCH METHODOLOGY & SCOPE

10.1.  RESEARCH SCOPE & DELIVERABLES

10.1.1.   OBJECTIVES OF STUDY

10.1.2.    SCOPE OF STUDY

10.2.  SOURCES OF DATA

10.2.1.   PRIMARY DATA SOURCES

10.2.2.   SECONDARY DATA SOURCES

10.3.  RESEARCH METHODOLOGY

10.3.1.   EVALUATION OF PROPOSED MARKET

10.3.2.   IDENTIFICATION OF DATA SOURCES

10.3.3.    ASSESSMENT OF MARKET DETERMINANTS

10.3.4.   DATA COLLECTION

10.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        GLOBAL STEM CELL MARKET, BY REGION, 2021-2028 (IN $ MILLION)

TABLE 2        VENDOR SCORECARD

TABLE 3        GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4        GLOBAL STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 5        GLOBAL ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6        GLOBAL PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 7        GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 8        GLOBAL STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 9        GLOBAL ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10      GLOBAL STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 11      GLOBAL STEM CELL MARKET, BY REGION, 2021-2028 (IN $ MILLION)

TABLE 12      NORTH AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 13      NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 14      NORTH AMERICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 15      NORTH AMERICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 16      NORTH AMERICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 17      NORTH AMERICA STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 18      NORTH AMERICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 19      NORTH AMERICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 20      NORTH AMERICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 21      EUROPE STEM CELL, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 22      EUROPE STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 23      EUROPE STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 24      EUROPE ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 25      EUROPE PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 26      EUROPE STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 27      EUROPE STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 28      EUROPE ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 29      EUROPE STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 30      ASIA-PACIFIC STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 31      ASIA-PACIFIC STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 32      ASIA-PACIFIC STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 33      ASIA-PACIFIC ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 34      ASIA-PACIFIC PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 35      ASIA-PACIFIC STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 36      ASIA-PACIFIC STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 37      ASIA-PACIFIC ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 38      ASIA-PACIFIC STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 39      LATIN AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 40      LATIN AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 41      LATIN AMERICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 42      LATIN AMERICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 43      LATIN AMERICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 44      LATIN AMERICA STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 45      LATIN AMERICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 46      LATIN AMERICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 47      LATIN AMERICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 48      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 49      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 50      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 51      MIDDLE EAST AND AFRICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 52      MIDDLE EAST AND AFRICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 53      MIDDLE EAST AND AFRICA STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 54      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 55      MIDDLE EAST AND AFRICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 56      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1      GLOBAL STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 2      GLOBAL STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 3      GLOBAL STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 4      GLOBAL STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

FIGURE 5      GLOBAL STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

FIGURE 6      GLOBAL STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7      GLOBAL STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 8      GLOBAL STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9      GLOBAL STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

FIGURE 10   GLOBAL STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

FIGURE 11   GLOBAL STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 12   GLOBAL STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

FIGURE 13   GLOBAL STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

FIGURE 14   GLOBAL STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 15   GLOBAL STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

FIGURE 16   GLOBAL STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 17   GLOBAL STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

FIGURE 18   GLOBAL STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

FIGURE 19   GLOBAL STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 20   GLOBAL STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 21   GLOBAL STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 22   GLOBAL STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 23   GLOBAL STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 24   GLOBAL STEM CELL MARKET, BY NEURAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 25   GLOBAL STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 26   GLOBAL STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 27   GLOBAL STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 28   GLOBAL STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 29   GLOBAL STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

FIGURE 30   GLOBAL STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

FIGURE 31   GLOBAL STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 32   GLOBAL STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

FIGURE 33   UNITED STATES STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 34   CANADA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 35   GERMANY STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 36   FRANCE STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 37   UNITED KINGDOM STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 38   ITALY STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 39   RUSSIA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 40   SPAIN STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 41   REST OF EUROPE STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 42   CHINA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 43   JAPAN STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 44   INDIA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 45   AUSTRALIA & NEW ZEALAND STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 46   SOUTH KOREA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 47   ASEAN COUNTRIES STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 48   REST OF ASIA-PACIFIC STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 49   MEXICO STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 50   BRAZIL STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 51   REST OF LATIN AMERICA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 52   ISRAEL STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 53   SAUDI ARABIA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 54   UNITED ARAB EMIRATES STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 55   TURKEY STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 56   SOUTH AFRICA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 57   REST OF MIDDLE EAST & AFRICA STEM CELL MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;